BR100 Increased By (0.52%)
BR30 Increased By (0.44%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.58%)
BECO 5.67 Decreased By ▼ -0.06 (-1.05%)
BML 57.05 Decreased By ▼ -0.25 (-0.44%)
BOP 36.85 Increased By ▲ 0.08 (0.22%)
CNERGY 8.32 Decreased By ▼ -0.07 (-0.83%)
DCL 11.90 Decreased By ▼ -0.14 (-1.16%)
FCCL 58.66 Increased By ▲ 0.05 (0.09%)
FCSC 5.09 Increased By ▲ 0.08 (1.6%)
FFL 18.12 Increased By ▲ 0.18 (1%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.28 Decreased By ▼ -0.14 (-1.23%)
KEL 8.24 Decreased By ▼ -0.05 (-0.6%)
KOSM 6.54 Decreased By ▼ -0.08 (-1.21%)
MLCF 107.17 Decreased By ▼ -1.12 (-1.03%)
NBP 208.80 Increased By ▲ 2.76 (1.34%)
PACE 11.18 Increased By ▲ 0.01 (0.09%)
PAEL 45.39 Increased By ▲ 0.04 (0.09%)
PIAHCLA 30.31 Decreased By ▼ -0.46 (-1.49%)
PIBTL 18.87 Decreased By ▼ -0.19 (-1%)
PPL 248.71 Increased By ▲ 2.76 (1.12%)
PRL 36.29 Increased By ▲ 0.21 (0.58%)
PTC 74.01 Increased By ▲ 1.65 (2.28%)
SEARL 96.13 Decreased By ▼ -0.54 (-0.56%)
SSGC 31.37 Decreased By ▼ -0.30 (-0.95%)
TELE 9.21 Decreased By ▼ -0.06 (-0.65%)
THCCL 68.04 Increased By ▲ 0.23 (0.34%)
TPLP 11.64 Increased By ▲ 0.41 (3.65%)
TREET 25.72 Decreased By ▼ -0.17 (-0.66%)
TRG 67.62 Decreased By ▼ -0.22 (-0.32%)
WAVES 11.25 Increased By ▲ 0.27 (2.46%)
WTL 1.28 No Change ▼ 0.00 (0%)
Business & Finance

AstraZeneca COVID-19 vaccine could be on the market by end of 2020

  • We are talking about a potential vaccine so we need to be extremely prudent.
  • Drugmakers are racing to combat the pandemic, which has killed more than 850,000 people and infected over 25 million.
Published Updated
By

ROME: The first shots of British drug maker AstraZeneca's potential COVID-19 vaccine could be on the market by the end of 2020, Italian Health Minister Roberto Speranza said on Wednesday.

"We are talking about a potential vaccine so we need to be extremely prudent, but... if the vaccine is confirmed as safe and able to meet its objective it will be already available by the end of 2020," Speranza told parliament.

Drugmakers are racing to combat the pandemic, which has killed more than 850,000 people and infected over 25 million.

The European Commission has paid 336 million euros ($397.82 million) to AstraZeneca to secure at least 300 million doses of its potential vaccine for EU nations.

Comments

Comments are closed for this article.